regeneron pharmaceuticals
(REGN:NASDAQ GS)
Executive Profile*
Christine A. PoonDirector, Member of Compensation Committee and Member of Corporate Governance & Compliance Committee, Regeneron Pharmaceuticals, Inc. |
| Age | Total Calculated Compensation | This person is connected to 46 board members in 7 different organizations across 9 different industries. See Board Relationships |
| 60 | $515,425 |
Background*
Ms. Christine A. Poon, Chris, serves as the Dean of Ohio State University's Fisher College of Business. Ms. Poon served as the Worldwide Chairman of Medicines & Nutritionals of Johnson & Johnson since 2003. She served as the President of International Medicines of Bristol-Myers Squibb Company from 1998 to 2000 and also its President of Medical Devices from 1997 to 1998. Her areas of expertise include domestic and international business operations and sales and marketing. ...
Corporate Headquarters*777 Old Saw Mill River RoadTarrytown, New York 10591 United States Phone: 914-347-7000 Fax: 914-347-2113 Board Members Memberships*Director of The Prudential Insurance Company of America, Member of Finance & Dividends Committee and Member of Investment Committee Director Director of Prudential Insurance Company of America, Member of Finance & Dividends Committee and Member of Investment Committee 2005-2009 Former Vice Chairman, Member of Executive Committee, Member of Finance Committee and Member of Pension Committee 2006-Present Independent Director, Member of Finance Committee and Member of Investment Committee 2010-Present Director, Member of Compensation Committee and Member of Corporate Governance & Compliance Committee
Education*MBA 1982 Boston University BA 1973 Northwestern University MS 1976 Saint Louis University-St. Louis
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*
|
| Recently Viewed | |||
| REGN:US | $266.97 USD | +2.31 | |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Richard F. Pops | Chairman and Chief Executive Officer Alkermes plc | $775.0K |
| Jean-Jacques Bienaimé | Chief Executive Officer and Director BioMarin Pharmaceutical Inc. | $821.1K |
| N. Anthony Coles M.D., M.P.H. | Chairman, Chief Executive Officer and President Onyx Pharmaceuticals, Inc. | $740.0K |
| Jeffrey M. Leiden M.D., Ph.D. | Chairman, Chief Executive Officer and President Vertex Pharmaceuticals Incorporated | $1.0M |
| David E. I. Pyott | Chairman, Chief Executive Officer and President Allergan Inc. | $1.3M | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Thornton, CO | IntuitPosted: Apr 29
Sponsored Financial Commentaries
Sponsored Links
To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








